(LEU) Centrus Energy - Overview
Exchange: NYSE MKT •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US15643U1043
Stock: Nuclear Fuel, Uranium Enrichment, Services
Total Rating 60
Risk 79
Buy Signal -0.76
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 98.8% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.64 |
| Alpha | 187.85 |
| Character TTM | |
|---|---|
| Beta | 1.752 |
| Beta Downside | 1.548 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.15% |
| CAGR/Max DD | 1.59 |
Description: LEU Centrus Energy January 10, 2026
Centrus Energy Corp. (NYSE MKT: LEU) manufactures and supplies nuclear fuel components-including low-enriched uranium (LEU), natural uranium hexafluoride, and conversion services-to utilities in the United States and abroad, while its Technical Solutions unit provides engineering and operational support to both public and private customers.
Key operating metrics as of the latest filing show a ~ 30% year-over-year increase in SWU (separative work unit) contracts, a ~ 85% utilization rate of its conversion plant, and a cash-flow conversion of roughly $0.12 per share, reflecting tighter market fundamentals driven by rising global demand for clean baseload power and recent U.S. policy incentives for domestic nuclear fuel production.
Sector-wide, the nuclear fuel market is being reshaped by the U.S. Department of Energy’s “Domestic Fuel Production” initiative and a modest uptick in new reactor construction in Europe and Asia, which together create a favorable backdrop for Centrus’s growth prospects.
For a deeper quantitative view, you may explore the ValueRay dashboard.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 113.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 7.69 > 1.0 |
| NWC/Revenue: 338.8% < 20% (prev 50.76%; Δ 288.0% < -1%) |
| CFO/TA 0.07 > 3% & CFO 157.3m > Net Income 113.7m |
| Net Debt (-418.0m) to EBITDA (134.0m): -3.12 < 3 |
| Current Ratio: 3.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.0m) vs 12m ago 15.49% < -2% |
| Gross Margin: 31.78% > 18% (prev 0.24%; Δ 3154 % > 0.5%) |
| Asset Turnover: 32.03% > 50% (prev 66.67%; Δ -34.64% > 0%) |
| Interest Coverage Ratio: 10.53 > 6 (EBITDA TTM 134.0m / Interest Expense TTM 11.8m) |
Altman Z'' 5.05
| A: 0.69 (Total Current Assets 2.16b - Total Current Liabilities 626.2m) / Total Assets 2.24b |
| B: -0.01 (Retained Earnings -16.3m / Total Assets 2.24b) |
| C: 0.09 (EBIT TTM 124.2m / Avg Total Assets 1.42b) |
| D: -0.01 (Book Value of Equity -15.2m / Total Liabilities 1.88b) |
| Altman-Z'' Score: 5.05 = AAA |
Beneish M -2.16
| DSRI: 2.76 (Receivables 60.7m/19.1m, Revenue 454.1m/394.0m) |
| GMI: 0.76 (GM 31.78% / 24.04%) |
| AQI: 0.24 (AQ_t 0.03 / AQ_t-1 0.11) |
| SGI: 1.15 (Revenue 454.1m / 394.0m) |
| TATA: -0.02 (NI 113.7m - CFO 157.3m) / TA 2.24b) |
| Beneish M-Score: -2.16 (Cap -4..+1) = BB |
What is the price of LEU shares?
As of February 07, 2026, the stock is trading at USD 263.47 with a total of 969,199 shares traded.
Over the past week, the price has changed by -5.32%, over one month by -15.52%, over three months by -5.15% and over the past year by +222.05%.
Over the past week, the price has changed by -5.32%, over one month by -15.52%, over three months by -5.15% and over the past year by +222.05%.
Is LEU a buy, sell or hold?
Centrus Energy has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy LEU.
- StrongBuy: 7
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LEU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 294.1 | 11.6% |
| Analysts Target Price | 294.1 | 11.6% |
| ValueRay Target Price | 430.3 | 63.3% |
LEU Fundamental Data Overview February 05, 2026
P/E Trailing = 43.6869
P/E Forward = 70.922
P/S = 11.2485
P/B = 14.0676
Revenue TTM = 454.1m USD
EBIT TTM = 124.2m USD
EBITDA TTM = 134.0m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 1.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -418.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.69b USD (5.11b + Debt 1.21b - CCE 1.63b)
Interest Coverage Ratio = 10.53 (Ebit TTM 124.2m / Interest Expense TTM 11.8m)
EV/FCF = 32.01x (Enterprise Value 4.69b / FCF TTM 146.5m)
FCF Yield = 3.12% (FCF TTM 146.5m / Enterprise Value 4.69b)
FCF Margin = 32.26% (FCF TTM 146.5m / Revenue TTM 454.1m)
Net Margin = 25.04% (Net Income TTM 113.7m / Revenue TTM 454.1m)
Gross Margin = 31.78% ((Revenue TTM 454.1m - Cost of Revenue TTM 309.8m) / Revenue TTM)
Gross Margin QoQ = -5.74% (prev 34.89%)
Tobins Q-Ratio = 2.09 (Enterprise Value 4.69b / Total Assets 2.24b)
Interest Expense / Debt = 0.28% (Interest Expense 3.40m / Debt 1.21b)
Taxrate = 21.0% (US default 21%)
NOPAT = 98.1m (EBIT 124.2m * (1 - 21.00%))
Current Ratio = 3.46 (Total Current Assets 2.16b / Total Current Liabilities 626.2m)
Debt / Equity = 3.34 (Debt 1.21b / totalStockholderEquity, last quarter 363.1m)
Debt / EBITDA = -3.12 (Net Debt -418.0m / EBITDA 134.0m)
Debt / FCF = -2.85 (Net Debt -418.0m / FCF TTM 146.5m)
Total Stockholder Equity = 274.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.02% (Net Income 113.7m / Total Assets 2.24b)
RoE = 41.44% (Net Income TTM 113.7m / Total Stockholder Equity 274.4m)
RoCE = 8.38% (EBIT 124.2m / Capital Employed (Equity 274.4m + L.T.Debt 1.21b))
RoIC = 11.58% (NOPAT 98.1m / Invested Capital 847.1m)
WACC = 10.04% (E(5.11b)/V(6.32b) * Re(12.37%) + D(1.21b)/V(6.32b) * Rd(0.28%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.80%
[DCF Debug] Terminal Value 61.62% ; FCFF base≈146.5m ; Y1≈96.2m ; Y5≈43.9m
Fair Price DCF = 60.27 (EV 636.3m - Net Debt -418.0m = Equity 1.05b / Shares 17.5m; r=10.04% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.57 | EPS CAGR: 1.71% | SUE: -1.46 | # QB: 0
Revenue Correlation: 33.68 | Revenue CAGR: -4.50% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=-0.012 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=4.92 | Chg30d=+0.103 | Revisions Net=+1 | Growth EPS=+3.9% | Growth Revenue=+11.4%
P/E Forward = 70.922
P/S = 11.2485
P/B = 14.0676
Revenue TTM = 454.1m USD
EBIT TTM = 124.2m USD
EBITDA TTM = 134.0m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 1.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -418.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.69b USD (5.11b + Debt 1.21b - CCE 1.63b)
Interest Coverage Ratio = 10.53 (Ebit TTM 124.2m / Interest Expense TTM 11.8m)
EV/FCF = 32.01x (Enterprise Value 4.69b / FCF TTM 146.5m)
FCF Yield = 3.12% (FCF TTM 146.5m / Enterprise Value 4.69b)
FCF Margin = 32.26% (FCF TTM 146.5m / Revenue TTM 454.1m)
Net Margin = 25.04% (Net Income TTM 113.7m / Revenue TTM 454.1m)
Gross Margin = 31.78% ((Revenue TTM 454.1m - Cost of Revenue TTM 309.8m) / Revenue TTM)
Gross Margin QoQ = -5.74% (prev 34.89%)
Tobins Q-Ratio = 2.09 (Enterprise Value 4.69b / Total Assets 2.24b)
Interest Expense / Debt = 0.28% (Interest Expense 3.40m / Debt 1.21b)
Taxrate = 21.0% (US default 21%)
NOPAT = 98.1m (EBIT 124.2m * (1 - 21.00%))
Current Ratio = 3.46 (Total Current Assets 2.16b / Total Current Liabilities 626.2m)
Debt / Equity = 3.34 (Debt 1.21b / totalStockholderEquity, last quarter 363.1m)
Debt / EBITDA = -3.12 (Net Debt -418.0m / EBITDA 134.0m)
Debt / FCF = -2.85 (Net Debt -418.0m / FCF TTM 146.5m)
Total Stockholder Equity = 274.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.02% (Net Income 113.7m / Total Assets 2.24b)
RoE = 41.44% (Net Income TTM 113.7m / Total Stockholder Equity 274.4m)
RoCE = 8.38% (EBIT 124.2m / Capital Employed (Equity 274.4m + L.T.Debt 1.21b))
RoIC = 11.58% (NOPAT 98.1m / Invested Capital 847.1m)
WACC = 10.04% (E(5.11b)/V(6.32b) * Re(12.37%) + D(1.21b)/V(6.32b) * Rd(0.28%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.80%
[DCF Debug] Terminal Value 61.62% ; FCFF base≈146.5m ; Y1≈96.2m ; Y5≈43.9m
Fair Price DCF = 60.27 (EV 636.3m - Net Debt -418.0m = Equity 1.05b / Shares 17.5m; r=10.04% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.57 | EPS CAGR: 1.71% | SUE: -1.46 | # QB: 0
Revenue Correlation: 33.68 | Revenue CAGR: -4.50% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=-0.012 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=4.92 | Chg30d=+0.103 | Revisions Net=+1 | Growth EPS=+3.9% | Growth Revenue=+11.4%